» Articles » PMID: 39859485

Cellular Senescence in Hepatocellular Carcinoma: Immune Microenvironment Insights Via Machine Learning and In Vitro Experiments

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2025 Jan 25
PMID 39859485
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC), a leading liver tumor globally, is influenced by diverse risk factors. Cellular senescence, marked by permanent cell cycle arrest, plays a crucial role in cancer biology, but its markers and roles in the HCC immune microenvironment remain unclear. Three machine learning methods, namely k nearest neighbor (KNN), support vector machine (SVM), and random forest (RF), are utilized to identify eight key HCC cell senescence markers (HCC-CSMs). Consensus clustering revealed molecular subtypes. The single-cell analysis explored the tumor microenvironment, immune checkpoints, and immunotherapy responses. In vitro, RNA interference mediated knockdown, and co-culture experiments assessed its impact. Cellular senescence-related genes predicted HCC survival information better than differential expression genes (DEGs). Eight key HCC-CSMs were identified, which revealed two distinct clusters with different clinical characteristics and mutation patterns. By single-cell RNA-seq data, we investigated the immunological microenvironment and observed that increasing immune cells allow hepatocytes to regain population dominance. This phenomenon may be associated with the HCC-CSMs identified in our study. By combining bulk RNA sequencing and single-cell RNA sequencing data, we identified the key gene and the natural killer (NK) cells that express at the highest levels. knockdown increased NK cell proliferation but reduced function, potentially aiding tumor survival. These findings provide insights into senescence-driven HCC progression and potential therapeutic targets.

References
1.
Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

2.
Forner A, Reig M, Rodriguez de Lope C, Bruix J . Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010; 30(1):61-74. DOI: 10.1055/s-0030-1247133. View

3.
Pei S, Zhang P, Yang L, Kang Y, Chen H, Zhao S . Exploring the role of sphingolipid-related genes in clinical outcomes of breast cancer. Front Immunol. 2023; 14:1116839. PMC: 9968761. DOI: 10.3389/fimmu.2023.1116839. View

4.
Penuelas-Haro I, Espinosa-Sotelo R, Crosas-Molist E, Herranz-Iturbide M, Caballero-Diaz D, Alay A . The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression. Hepatology. 2022; 78(2):416-433. PMC: 10344438. DOI: 10.1002/hep.32702. View

5.
Liu X, Si F, Bagley D, Ma F, Zhang Y, Tao Y . Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy. J Immunother Cancer. 2022; 10(10). PMC: 9535198. DOI: 10.1136/jitc-2022-005020. View